{"version":3,"sources":["webpack:///path---assignments-yx-nza-wdub-w-vud-do-3-ode-3-2f36f45614c696717378.js","webpack:///./.cache/json/assignments-yx-nza-wdub-w-vud-do-3-ode-3.json"],"names":["webpackJsonp","1241","module","exports","data","assignments","id","title","description","pathContext"],"mappings":"AAAAA,cAAc,iBAERC,KACA,SAAUC,EAAQC,GCHxBD,EAAAC,SAAkBC,MAAQC,aAAeC,GAAA,uBAAAC,MAAA,gEAAAC,YAAA,yRAA0YC,aAAgBH,GAAA","file":"path---assignments-yx-nza-wdub-w-vud-do-3-ode-3-2f36f45614c696717378.js","sourcesContent":["webpackJsonp([268319268510023],{\n\n/***/ 1241:\n/***/ (function(module, exports) {\n\n\tmodule.exports = {\"data\":{\"assignments\":{\"id\":\"YXNzaWdubWVudDo3ODE3\",\"title\":\"MIT researchers develop glucose-responsive diabetes treatment\",\"description\":\"Researchers at MIT have developed a new method for tackling diabetes that could represent a significant breakthrough in treating the condition. The team's engineered insulin stays in the patient’s bloodstream, but is only activated when sugar levels start to tip the scales.  \"}},\"pathContext\":{\"id\":\"YXNzaWdubWVudDo3ODE3\"}}\n\n/***/ })\n\n});\n\n\n// WEBPACK FOOTER //\n// path---assignments-yx-nza-wdub-w-vud-do-3-ode-3-2f36f45614c696717378.js","module.exports = {\"data\":{\"assignments\":{\"id\":\"YXNzaWdubWVudDo3ODE3\",\"title\":\"MIT researchers develop glucose-responsive diabetes treatment\",\"description\":\"Researchers at MIT have developed a new method for tackling diabetes that could represent a significant breakthrough in treating the condition. The team's engineered insulin stays in the patient’s bloodstream, but is only activated when sugar levels start to tip the scales.  \"}},\"pathContext\":{\"id\":\"YXNzaWdubWVudDo3ODE3\"}}\n\n\n//////////////////\n// WEBPACK FOOTER\n// ./~/json-loader!./.cache/json/assignments-yx-nza-wdub-w-vud-do-3-ode-3.json\n// module id = 1241\n// module chunks = 268319268510023"],"sourceRoot":""}